Arcutis Biotherapeutics, Inc. (ARQT)

22.78 +1.24 (+5.78%) USD  |  NASDAQ  |  Jun 09, 16:00
22.70 -0.08 (-0.37%) After-Hours: 18:03
More

Arcutis Biotherapeutics SG&A Expense (Quarterly) : 74.08M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 171.02M
Incyte Corp. 328.09M
MannKind Corp. 108.17M
PTC Therapeutics, Inc. 86.18M
Capricor Therapeutics, Inc. 9.396M